Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Credit Suisse downgraded Darden Restaurants, Inc. (NYSE: DRI) from Outperform to Neutral. Darden shares fell 0.45 percent to $73.60 in pre-market trading.
- Analysts at Macquarie downgraded AK Steel Holding Corporation (NYSE: AKS) from Outperform to Neutral. AK Steel shares fell 3.52 percent to $8.78 in pre-market trading.
- Longbow Research downgraded Carlisle Companies, Inc. (NYSE: CSL) from Buy to Neutral. Carlisle shares fell 1.37 percent to close at $114.37 on Monday.
- Nomura downgraded Goldman Sachs Group Inc (NYSE: GS) from Buy to Neutral. Goldman Sachs shares dropped 0.27 percent to $209.79 in pre-market trading.
- Analysts at Argus Research downgraded United States Steel Corporation (NYSE: X) from Buy to Hold. United States Steel shares fell 3.64 percent to $31.00 in pre-market trading.
- Barclays downgraded Johnson & Johnson (NYSE: JNJ) from Overweight to Equal-Weight. Johnson & Johnson shares fell 0.22 percent to $112.88 in pre-market trading.
- Analysts at Goldman Sachs downgraded Wendys Co (NASDAQ: WEN) from Buy to Neutral. Wendy's shares dropped 0.38 percent to close at $12.94 on Monday.
- Keefe Bruyette & Woods downgraded KeyCorp (NYSE: KEY) from Outperform to Market Perform. KeyCorp shares slipped 0.59 percent to $16.90 in pre-market trading.
- KeyBanc downgraded Greif, Inc. (NYSE: GEF) from Hold to Underweight. Greif shares fell 0.02 percent to $54.33 in pre-market trading.
- Analysts at Baird downgraded Nivalis Therapeutics Inc (NASDAQ: NVLS) from Outperform to Neutral. Nivalis Therapeutics shares dropped 54.08 percent to $2.87 in pre-market trading.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.